Summary: Researchers have traced the earliest cellular origins of Rett syndrome by isolating genetically healthy and mutant brain cells from the same mosaic female hippocampus before analysis. This approach revealed a presymptomatic molecular signature and a uniquely vulnerable neuron type that help explain how the disorder begins long before symptoms appear.
Using a combination of bulk and single-nucleus RNA sequencing on hippocampal tissue, the team identified a core set of 12 genes whose dysregulation precedes visible symptoms and pinpointed a specialized cell type—the trilaminar interneuron—as particularly susceptible to MECP2 mutation. The study also shows how mutant cells can alter nearby healthy cells, creating a toxic local environment that contributes to broad circuit dysfunction.
Key Facts
- The mosaic challenge: Rett syndrome results from mutations in the X-linked regulator gene MECP2. Because females undergo random X-chromosome inactivation, their brains are mosaics of MeCP2-positive (healthy) and MeCP2-negative (mutant) cells. This mixture has historically hidden early molecular changes when tissues were analyzed in bulk.
- Separating cell populations: To overcome dilution of mutant signals, the research group physically separated MeCP2-positive and MeCP2-negative cells from the same mosaic female hippocampus, allowing direct comparison of gene expression in matched healthy and mutant cells.
- 12‑gene presymptomatic signature: Cross-sex comparisons revealed a compact, consistent set of 12 genes disrupted at presymptomatic stages in mutant cells. Many of these genes are involved in synapse formation and function, indicating that synaptic failure is an early and central event in Rett pathogenesis.
- Trilaminar interneurons identified: Single-nucleus profiling uncovered an unexpected cellular target: trilaminar interneurons, which span multiple hippocampal layers to coordinate information flow. These cells showed the strongest transcriptional disturbance of any neuronal subtype when MECP2 function was lost.
- Neighborhood, not just genotype: The study demonstrates non–cell autonomous effects: genetically normal (MeCP2-positive) cells within mosaic female brains still show altered gene expression when surrounded by mutant neighbors, revealing how a distorted microenvironment amplifies disease impact.
- Implications for early intervention: The cell-specific molecular markers and the identified vulnerable cell type offer objective biomarkers and potential early therapeutic targets. Protecting trilaminar interneurons or correcting the 12-gene signature before symptom onset could open a crucial window to slow or prevent disease progression.
Source: Baylor College of Medicine
Study overview: Investigators at Baylor College of Medicine and the Duncan Neurological Research Institute at Texas Children’s Hospital analyzed hippocampal cells from mouse models of Rett syndrome at presymptomatic stages. By profiling gene expression at single-cell resolution and in bulk, they identified early molecular disruptions and cell types that are selectively vulnerable to MECP2 loss.
Rett syndrome is a rare neurodevelopmental disorder that overwhelmingly affects girls. Children with Rett syndrome typically appear to develop normally during early infancy, but between about 6 and 18 months of age they often lose acquired skills such as purposeful hand use, speech, and social engagement.
“Rett syndrome is caused by mutations in MECP2, a gene that helps regulate expression of many other genes in neurons,” said Dr. Huda Zoghbi, corresponding author and director of the Duncan NRI. Loss of MECP2 function disrupts regulation across thousands of downstream targets, and because MECP2 is X-linked, males and females experience different cellular landscapes.
Female cells have two X chromosomes and randomly inactivate one, producing a mosaic brain composed of roughly half MeCP2-positive and half MeCP2-negative cells. Male brains, with a single X chromosome, are uniformly MeCP2-deficient and typically show more severe early-onset disease.
The research team focused on the hippocampus, a brain region crucial for learning and memory and known to be affected early in Rett syndrome. A key advance in the study was physically separating MeCP2-positive from MeCP2-negative cells before sequencing, enabling the first direct comparison of matched healthy and mutant cells from the same female brain.
Combining bulk RNA sequencing, which captures tissue-wide changes, with single-nucleus RNA sequencing, which reveals cell-type specific effects, allowed the researchers to see both the broad context and the precise cellular details. Bulk measures appeared modest in females because healthy cells diluted signals from mutant cells, but single-cell analysis exposed strong, cell-specific dysregulation hidden in bulk data.
Two co-first authors, Dr. Ashley Anderson and Yan Li, identified 12 genes that were consistently altered early in mutant cells regardless of sex. Many of these genes are linked to synaptic structure and signaling, supporting the idea that impaired neuronal communication is a primary event in disease onset.
The study also showed that MeCP2-positive cells in female brains are influenced by nearby MeCP2-negative cells: gene expression in genetically normal neurons is altered by their local environment. This non–cell autonomous, neighborhood effect helps explain why Rett syndrome causes widespread brain dysfunction even though many neurons carry a healthy MECP2 allele.
An unexpected and important finding was the vulnerability of trilaminar interneurons. These interneurons coordinate activity across hippocampal layers and displayed the greatest transcriptional disruption in both male and female models, marking them as a promising cellular target for protective strategies.
“Defining early, cell-specific molecular changes gives us measurable markers to assess therapies and points to where interventions might be most effective,” Zoghbi said. “Targeting the earliest disruptions or protecting the most susceptible cell types could help prevent clinical decline.”
Additional contributors include Guantong Qi, Sih-Rong Wu, Jean-Pierre Revelli, Hu Chen and Zhandong Liu, affiliated with Baylor College of Medicine and the Duncan NRI.
Funding: Supported by the National Institute of Neurological Disorders and Stroke (R01NS057819, F32N122920-01A1) and the Howard Hughes Medical Institute. Additional core facility and instrumentation support came from institutional and NIH resources, including the IDDRC grant P50 HD103555.
Key Questions Answered:
A: Early molecular damage accumulates in specific mutant neurons before clinical signs appear. This study shows that a core set of 12 synapse-related genes is disrupted inside mutant cells at presymptomatic stages. When enough neuronal connections fail, the brain can no longer compensate, and symptoms emerge between about 6 and 18 months.
A: Mosaicism means the brain contains a mixture of genetically different cells. Because MECP2 is X-linked and females randomly inactivate one X chromosome per cell, a girl with Rett syndrome has both healthy and mutant cells. When researchers previously analyzed mixed tissue, signals from healthy cells masked early changes in mutant cells.
A: Trilaminar interneurons are specialized inhibitory neurons that bridge multiple hippocampal layers to coordinate information flow. The study found that these interneurons experience disproportionately strong gene disruption when MECP2 fails, making them a precise cellular target for protective or restorative therapies.
Editorial Notes:
- Edited by a Neuroscience News editor.
- Journal paper reviewed in full by staff.
- Additional context provided by the editorial team.
About this autism and genetics research news
Author: Graciela Gutierrez
Source: Baylor College of Medicine
Contact: Graciela Gutierrez – Baylor College of Medicine
Image credit: Neuroscience News
Original Research: Open access. “Single-nucleus profiling reveals a core disease signature and cell type–specific vulnerabilities in early Rett syndrome” by Yan Li, Ashley G. Anderson, Guantong Qi, Sih-Rong Wu, Jean-Pierre Revelli, Hu Chen, Zhandong Liu, and Huda Y. Zoghbi. DOI: 10.1126/sciadv.aeb4265
Abstract
Single-nucleus profiling reveals a core disease signature and cell type–specific vulnerabilities in early Rett syndrome
Rett syndrome (RTT) is an X-linked neurological disorder caused by MECP2 mutations, producing mosaic cellular environments in females and nonmosaic conditions in males. Despite females representing the majority of cases, the molecular consequences of mosaicism in presymptomatic stages have been unclear.
To illuminate early events, hippocampal transcriptomes from young female and male RTT mouse models were profiled using bulk and single-nucleus RNA sequencing. A core disease signature of 12 genes was identified in MeCP2‑negative cells across models, and non–cell autonomous effects were observed in female MeCP2‑positive excitatory neurons, indicating heightened vulnerability in mosaic circuits. Single-nucleus data also revealed a MeCP2‑negative interneuron subtype—trilaminar interneurons—with the most pronounced transcriptional dysregulation.
Together, these findings highlight how MeCP2 loss differentially affects excitatory and inhibitory circuits in mosaic versus nonmosaic environments and provide cellular and molecular entry points for early intervention and biomarker development in Rett syndrome.